Add to ORKGThis talk was about the use of biological therapies such as Tumour Necrosis Factor Inhibitor in the treatment of inflammatory arthritides such as Rheumatoid Arthritis, psoriatic arthritis and ankylosing spondyliti
During the last decades, the advent of biological therapies has revolutionized the management of sev...
Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis belong among serious disorders,...
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthr...
This talk was about the use of biological therapies such as Tumour Necrosis Factor Inhibitor in the ...
Biologic drugs, introduced in clinical practice almost twenty years ago, represent nowadays a promin...
Fabrizio Cantini, Carlotta Nannini, Laura NiccoliSecond Division of Medicine, Rheumatology Unit, Hos...
Rheumatoid arthritis (RA) remains a major clinical problem, but treatments involving biologics have ...
Biologic drugs for the management of rheumatoid arthritis (RA) have revolutionized the therapeutic a...
Biologics are becoming important in the treatment of systemic and cutaneous autoimmune diseases. The...
Biologic drugs for the management of rheumatoid arthritis (RA) have revolutionized the therapeutic a...
Rheumatoid arthritis (RA) and juvenile idiopathic/rheumatoid arthritis (JIA) are chronic, inflammato...
Rheumatoid arthritis (RA) is a chronic inflammatory arthritis of the synovial joints that causes los...
The pathogenesis of rheumatoid arthritis (RA) is characterised by interactions between several types...
The tumor necrosis factor (TNF) inhibitors are protein constructs which bind and inactivate TNF. The...
The advent of biological agents has provided further opportunities to treat resistant or relapsing r...
During the last decades, the advent of biological therapies has revolutionized the management of sev...
Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis belong among serious disorders,...
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthr...
This talk was about the use of biological therapies such as Tumour Necrosis Factor Inhibitor in the ...
Biologic drugs, introduced in clinical practice almost twenty years ago, represent nowadays a promin...
Fabrizio Cantini, Carlotta Nannini, Laura NiccoliSecond Division of Medicine, Rheumatology Unit, Hos...
Rheumatoid arthritis (RA) remains a major clinical problem, but treatments involving biologics have ...
Biologic drugs for the management of rheumatoid arthritis (RA) have revolutionized the therapeutic a...
Biologics are becoming important in the treatment of systemic and cutaneous autoimmune diseases. The...
Biologic drugs for the management of rheumatoid arthritis (RA) have revolutionized the therapeutic a...
Rheumatoid arthritis (RA) and juvenile idiopathic/rheumatoid arthritis (JIA) are chronic, inflammato...
Rheumatoid arthritis (RA) is a chronic inflammatory arthritis of the synovial joints that causes los...
The pathogenesis of rheumatoid arthritis (RA) is characterised by interactions between several types...
The tumor necrosis factor (TNF) inhibitors are protein constructs which bind and inactivate TNF. The...
The advent of biological agents has provided further opportunities to treat resistant or relapsing r...
During the last decades, the advent of biological therapies has revolutionized the management of sev...
Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis belong among serious disorders,...
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthr...